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Cataplexy-Active Neurons in the Hypothalamus:
Implications for the Role of Histamine
in Sleep and Waking Behavior
taminergic (Sakai et al., 1990; Strecker et al., 2002) cells
are continuously and maximally active in waking but are
minimally active or silent in REM sleep. The cessation
of activity of these monoaminergic neurons might under-
lie the loss of muscle tone and loss of environmental
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3 Brain Research Institute Cataplexy is a sudden loss of muscle tone in waking,
usually triggered by laughter or the strong, sudden onsetUniversity of California, Los Angeles
Los Angeles, California 90095 of emotions in humans with narcolepsy (Guilleminault,
1976). In canine narcoleptics, cataplexy is triggered by
emotional excitement, play, or the consumption of fa-
vored foods (Siegel, 1999; Wu et al., 1999). Waking andSummary
a low-voltage EEG are maintained during cataplectic
attacks (Guilleminault, 1976). Humans report being alert,Noradrenergic, serotonergic, and histaminergic neu-
rons are continuously active during waking, reduce with clear perception and accurate memory of events
occurring during cataplexy, and both human and caninedischarge during NREM sleep, and cease discharge
during REM sleep. Cataplexy, a symptom associated narcoleptics can visually track objects during this state.
However, skeletal muscle tone is absent or greatly de-with narcolepsy, is a waking state in which muscle
tone is lost, as it is in REM sleep, while environmental creased. Thus, cataplexy represents a unique natural
experiment in which muscle atonia is dissociated fromawareness continues, as in alert waking. In prior work,
we reported that, during cataplexy, noradrenergic sleep. If the activity of one or more of the monoaminergic
cell groups is correlated with muscle tone, one wouldneurons cease discharge, and serotonergic neurons
greatly reduce activity. We now report that, in contrast expect that these cells would cease discharge in cata-
plexy. If their activity is linked to waking, one wouldto these other monoaminergic “REM-off” cell groups,
histamine neurons are active in cataplexy at a level predict that they would maintain their discharge during
cataplexy. We have previously reported that noradrener-similar to or greater than that in quiet waking. We
hypothesize that the activity of histamine cells is linked gic cells of the locus coeruleus (LC) cease discharge
during cataplexy (Wu et al., 1999) and that serotonergicto the maintenance of waking, in contrast to activity
in noradrenergic and serotonergic neurons, which is cells reduce discharge to NREM sleep levels during cat-
aplexy (Wu et al., 2004). We now report that histaminer-more tightly coupled to the maintenance of muscle
tone in waking and its loss in REM sleep and cataplexy. gic cells maintain waking levels of activity during cata-
plexy and, unlike noradrenergic and serotonergic cells,
do not alter their discharge rate after the administrationIntroduction
of drugs that increase the occurrence of cataplexy.
These data suggest separate roles for different mono-REM sleep and waking share certain physiological traits,
including a low-voltage electroencephalogram (EEG), aminergic cell groups in the regulation of muscle tone
and environmental awareness and in the pathophysiol-similar evoked responses to sensory stimuli, and activa-
tion of brain motor and autonomic control systems ogy of narcolepsy.
(Baust et al., 1972; Salin-Pascual et al., 2001). However,
there are also striking differences between the two Results
states. By definition, an animal is aware of its environ-
ment during waking, whereas in REM sleep it is not. In We recorded a total of 156 neurons in the ventral poste-
waking, muscle tone is continuously present, but, in rior lateral hypothalamus (PLH) across the sleep-wake
REM sleep, tone in the antigravity muscles is absent. (S-W) cycle, of which 88 cells were further studied during
The physiological and neurochemical mechanisms me- cataplexy episodes (Table 1). The recorded cells were
diating these differences between waking and REM categorized into seven types according to their S-W
sleep are unclear. discharge pattern: REM-off, NREM-off, wake/REM-
One possible substrate for the differences between active, wake-active, REM-active, state independent,
the behavioral and physiological conditions in waking and other (Table 1). The REM-off cells that we recorded
and REM sleep is the activity of monoaminergic neurons. from the tuberomammillary area of the posterior hypo-
Although most brain neurons show high levels of activity thalamus fulfilled the anatomical and physiological crite-
in both waking and REM sleep (Siegel, 2000; Steriade ria for histamine-containing cells, as described below.
et al., 1993), serotonergic (Jacobs and Azmitia, 1992),
noradrenergic (Aston-Jones and Bloom, 1981), and his- Characterization of Histaminergic REM-Off Cells
The tuberomammillary REM-off cells that we report on
here have the following properties. (1) They are located*Correspondence: jsiegel@ucla.edu
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Table 1. Average Discharge Rates of Posterior Lateral Hypothalamus Neurons during Waking, Sleep, and Cataplexy
Cell Type N AW QW NREM REM CAT
Wake/REM-active (all) 77 (49.4%) 3.42  0.45 2.46  0.37 1.44  0.21 3.07  0.41
Wake/REM-active (CAT-tested) 45 4.44  0.68 3.30  0.57 1.74  0.31 3.82  0.63 4.00  0.77
Wake-active (all) 19 (12.2%) 4.10  1.14 3.39  1.06 2.49  0.79 1.85  0.60
Wake-active (CAT-tested) 9 2.71  1.73 2.00  1.45 1.56  1.16 1.40  1.12 2.19  1.51
REM-off (all) 14 (9.0%) 4.76  0.86 1.93  0.65 0.61  0.29 0.30  0.07
REM-off (CAT-tested) 9 5.32  1.23 2.06  1.00 0.87  0.44 0.38  0.08 3.36  0.94
NREM-off (all) 12 (7.7%) 2.56  0.85 0.74  0.36 0.21  0.07 0.68  0.17
NREM-off (CAT-tested) 9 2.75  0.97 0.78  0.28 0.24  0.08 0.64  0.22 1.43  0.51
REM-active (all) 7 (4.5%) 0.45  0.17 0.70  0.40 1.17  0.50 2.15  0.76
REM-active (CAT-tested) 5 0.53  0.24 0.86  0.57 1.36  0.72 2.61  1.03 1.33  0.88
State independent (all) 11 (7.0%) 7.93  2.34 7.68  2.24 7.42  2.16 7.66  2.25
State independent (CAT-tested) 5 4.06  1.66 3.87  1.88 4.03  1.73 4.12  1.83 4.25  1.63
Other (all) 16 (10.2%) 4.93  1.76 3.43  0.80 3.60  1.06 3.39  1.12
Other (CAT-tested) 6 9.99  4.21 4.84  1.87 6.83  2.40 6.01  2.84 9.68  3.83
Discharge rates (Hz) are mean  SEM. Percentages of cells recorded (total n  156) are given in parentheses. AW, active waking; QW, quiet
waking; NREM, non-REM sleep; REM, REM sleep; CAT, cataplexy.
within the histamine cell region, as identified by immuno- cells (p 0.01 for both; Dunn’s [Bonferroni] test; Figures
1C and 1D). The spike width of the REM-off cells wasstaining. (2) They have long-duration action potentials,
in contrast to adjacent cells (Sakai et al., 1990; Vanni- also significantly greater than those of wake-active
(1.7  0.1 ms), NREM-off (1.7  0.08 ms), and state-Mercier et al., 2003). Acute and in vitro studies have
demonstrated that posterior hypothalamic cells with independent (1.7 0.1 ms) cells (p 0.05 for all; Dunn’s
[Bonferroni] test; Figures 1C and 1D). No significant dif-long-duration action potentials are histaminergic (Reiner
and McGeer, 1987; Uteshev et al., 1995). (3) They have ferences were seen among the spike widths of other
cell types.a wake-active-REM-off pattern of activity, in contrast to
adjacent cells, most of which are active in both waking
and REM sleep (Sakai et al., 1990; Vanni-Mercier et al., REM-Off Cells Had Similar Discharge Rates
in Quiet Waking and Cataplexy2003). This REM-off pattern was observed in dialysis
studies that measured histamine release from the poste- REM-off cells had their highest firing rates in active wak-
ing (AW) and reduced their discharge rates in QW andrior hypothalamus, with high and uniform levels seen
during waking, reduced levels in NREM sleep, and mini- NREM sleep; they exhibited very low discharge rates or
complete cessation of activity throughout REM sleepmal levels in REM sleep, exactly tracking the unit activity
profile that we report (Strecker et al., 2002). (Figure 2A; Table 1). REM sleep firing rates were signifi-
cantly lower than AW firing rates (t  5.7; df  13; p 
0.01; Bonferroni t test). The average activity rates in bothREM-Off Cells Were Recorded from the Region
Containing Histamine-IR Cells REM sleep (t  2.7; df  13; p  0.05; Bonferroni t test)
and NREM sleep (t  2.9; df  13; p  0.05; BonferroniHistamine-immunoreactive (histamine-IR) cells (20–50
m diameter) were largely concentrated in the tubero- t test) were also significantly lower than that in QW.
The average discharge rate of these cells in cataplexymammillary nucleus in the ventral PLH of the dog, as
described in other species (Figure 1A; Panula et al., was nonsignificantly higher than that in QW, nonsignifi-
cantly lower than that in AW, and significantly higher1984, 1990; Watanabe et al., 1984; Watanabe and Yanai,
2001). In addition, some large, bipolar histamine-IR neu- than those in NREM sleep (t  2.8; df  8; p  0.05;
Bonferroni t test) and REM sleep (t  3.4; df  8; p rons (30m diameter) were seen at the level of the fornix
and mammillothalamic tract in the posterior hypothala- 0.05; Bonferroni t test; Figures 2B and 3A–3C; Table 1).
This is in contrast to REM-off cells recorded from themus (Figure 1A1). REM-off cells were recorded from
microelectrodes that were located within the region that LC (Wu et al., 1999) and dorsal raphe (Wu et al., 2004),
which significantly reduce discharge in cataplexy rela-contained histamine-IR cells (Figure 1B). Reconstruc-
tion of the recording sites and mapping of the recorded tive to QW (Figure 4). The average firing rate of tubero-
mammillary hypothalamic REM-off cells during cata-neurons were done with the help of Nissl- and histamine-
stained sections (Figure 1B). The location of the cells plexy was 10.6 times their average firing rate in REM
sleep.was within a 1 mm anterior-posterior range of the section
illustrated in Figure 1B.
Effect of Cataplexy-Enhancing Drugs
on the Activity of REM-Off CellsREM-Off Cells Had Long Action Potential Duration
The spike widths (action potential durations) differed All three cataplexy-enhancing drugs that were tested
produced no significant change in the firing rate of pos-between cell groups defined on the basis of their dis-
charge rate profile (F  3.7; df  6,149; p  0.002; terior hypothalamic REM-off cells, as compared to the
pretreatment quiet waking state. After the administra-ANOVA). The spike width of the REM-off cells (2.3  0.2
ms) was significantly greater than those of wake/REM- tion of the anticholinesterase physostigmine salicylate
(n  6), the 1 adrenergic antagonist prazosin (n  2),active (1.8  0.04 ms) and REM-active (1.3  0.08 ms)
Histamine Cell Discharge in Cataplexy
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Figure 1. Identification and Characterization of Neurons Recorded from the Tuberomammillary Area of the Ventral Posterior Lateral Hypothala-
mic Region
(A) Photomicrograph showing histamine-immunostained cells located above the level of the fornix (A1), at the level of the fornix (A2), and
adjacent to the base of the brain (A3). The location of the electrode track within the histamine cell group is shown (A4). Arrows indicate the
histamine-immunoreactive cells along the electrode track. Scale bar for (A1) and (A2), 100 m; scale bar for (A3) and (A4), 100 m.
(B) Locations of histamine-immunostained neurons and recorded cell types. Histamine-immunostained cells (black dots) were concentrated
in the ventral posterior lateral hypothalamic region (ventral PLH). Scale bar, 1 mm. OT, optic tract; Fx, fornix; Mt, mammillothalamic tract.
(C) Action potentials of representative cells with different sleep-wake discharge profiles. Spike durations of the cells: wake-active, 1.8 ms;
wake/REM-active, 2.0 ms; NREM-off, 1.7 ms; REM-active, 1.3 ms; REM-off, 2.9 ms. Action potentials of state-independent and other cell
types are not shown. Calibration for unit action potentials: 1 ms and 50 V.
(D) The mean spike widths (ms)  SEM of the cell groups recorded from the ventral PLH region. SI, state independent. *p  0.05, **p  0.01.
and the 2 adrenergic agonist BHT-920 (n  3), these treatment levels (Figure 5A). The behavior of these cells
contrasts with that of LC and dorsal raphe cells, whichcells remained active or increased their firing rate during
the period before cataplexy onset, as compared to pre- reduce their discharge rate after administration of these
Neuron
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Figure 2. Activity of a PLH REM-Off Cell dur-
ing Sleep-Wake States and Cataplexy
(A) Unit activity in NREM sleep, REM sleep,
active waking, and cataplexy. Unit, single-cell
activity; EMG, electromyogram; Hipp, hippo-
campal electroencephalogram; EOG, electro-
oculogram; EEG, electroencephalogram; AW,
active waking; NREM, non-rapid eye move-
ment sleep; REM, rapid eye movement sleep;
CAT, cataplexy. Calibration bars: EMG, 100
V; Hipp, 50 V; EOG, 50 V; EEG, 50 V.
(B) Spike histogram based on an average of
nine cataplexy episodes (duration 50.6 
17.9 s) shows the discharge profile of a REM-
off neuron in AW prior to, during, and after
cataplexy. (Upper panel) Histograms of aver-
age discharge rates (400 ms bins) show
change in discharge rate from wake to onset
of cataplexy and from offset of cataplexy to
wake. (Lower panel) The corresponding aver-
aged electromyogram (EMG) shows atonia
with the onset of cataplexy (CAT-onset) and
increased activity with cataplexy offset (CAT-
offset) and in quiet waking (QW).
drugs and further reduce their rate immediately prior to other hand, the H1 antagonist mepyramine and the H3
(autoreceptor) agonist-methylhistamine did not signifi-and during spontaneous cataplexy attacks (Figure 5B;
Wu et al., 1999, 2004). cantly change the severity of cataplexy (Figure 5C).
Effect of Histaminergic and Noradrenergic
Reduction in GABA Release in CataplexyAntagonists on Cataplexy
High-pressure liquid chromatography (HPLC) analysisThe modified food elicited cataplexy test (Boehmer et
of microdialysis samples showed that -aminobutyrical., 2004) showed that intravenous administration of the
acid (GABA) release in the tuberomammillary region sig-1 antagonist prazosin significantly (p  0.05; Bonfer-
nificantly differed across S-W states and cataplexyroni t test) aggravated cataplexy (762.0  122.3 s), as
compared to saline controls (349.4  61.6 s). On the [F(3,66)  34.5; p  0.0001; ANOVA; Figure 5D]. GABA
Histamine Cell Discharge in Cataplexy
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Figure 3. Discharge Patterns of PLH REM-Off and NREM-Off Neurons
(A) Firing patterns of REM-off neurons across sleep-wake states (n  14).
(B) Mean discharge rates  SEM of REM-off neurons that were also recorded during cataplexy (n  9).
(C) Activity of REM-off neurons that were recorded during cataplexy and sleep-wake states.
(D) Firing patterns of NREM-off neurons that were recorded across sleep-wake states (n  12).
(E) Mean discharge rates  SEM of NREM-off neurons also recorded during cataplexy (n  9).
(F) Activity of NREM-off neurons across sleep-wake states and in cataplexy. AW, active waking; QW, quiet waking; NREM, non-rapid eye
movement sleep; REM, rapid eye movement sleep; CAT, cataplexy.
release was significantly higher in NREM sleep as com- those in NREM sleep (Figure 3D; t  4.8; df  11; p 
0.01; Bonferroni t test). Their mean firing rate in cata-pared to waking (p  0.05; Dunn’s [Bonferroni] test).
plexy was nonsignificantly higher than those in QW,Cataplexy (n  16) was accompanied by significant re-
NREM sleep, and REM sleep but lower than that in AWduction in GABA release, as compared to REM sleep
(Figures 3E and 3F; Table 1).(n  9), NREM sleep (n  23), and waking (n  15)
(p  0.01 for all; Dunn’s [Bonferroni] test), indicating that
Wake/REM-Active Cells Do Not Alter Theirhistamine neurons are disinhibited during cataplexy.
Firing Rate in Cataplexy Compared
with QW and REM Sleep
NREM-Off Cells Have Elevated Discharge Rates The largest group of cells recorded (49%) from the ven-
in REM, QW, and Cataplexy tral PLH was wake/REM-active neurons. These cells
NREM-off cells and the others listed below are pre- showed high discharge rates in both AW and REM sleep
sumed to be nonhistaminergic ventral PLH cells on the (Figure 6). Firing rates during NREM sleep were signifi-
basis of their spike widths and their discharge rate pro- cantly lower than those in AW (Figures 7A and 7B; t 
files across the S-W cycle. The transmitter(s) they re- 6.8; df  76; p  0.01; Bonferroni t test), QW (t  4.4;
lease is unknown. df  76; p  0.01; Bonferroni t test), and REM sleep (t 
A complete cessation of firing or a very slow firing 6.0; df  76; p  0.01; Bonferroni t test). The QW dis-
rate was seen in NREM-off cells during NREM sleep charge rate was also lower than those in REM sleep (t
(Figure 3D; Table 1). The firing rate was significantly 4.8; df  76; p  0.01; Bonferroni t test) and AW (t 
lower in NREM sleep than in AW (t  3.2; df  11; 8.2; df  76; p  0.01; Bonferroni t test). These cells
p  0.05; Bonferroni t test). These cells also showed were as active in cataplexy as in waking (Figure 7B). The
significantly lower firing rates in QW (t  3.6; df  11; average firing rate during cataplexy was significantly
p  0.01; Bonferroni t test) and REM sleep (t  2.7; df  higher than that in NREM sleep (t  4.3; df  44; p 
11; p  0.05; Bonferroni t test) than in AW, although 0.01; Bonferroni t test) but was not significantly different
from those in QW, AW, or REM sleep (Figure 7B; Table 1).firing rates in REM sleep were significantly higher than
Neuron
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Figure 4. Comparison of Mean Discharge Rates and Cataplexy-Related Activity of REM-Off Cells Recorded from Three Brain Regions
Posterior hypothalamic (histaminergic) neurons remained active, whereas dorsal raphe (serotonergic) neurons reduced discharge (Wu et al.,
2004), and locus coeruleus (noradrenergic) neurons ceased discharge (Wu et al., 1999) during cataplexy. All of these cell types were active
in waking, reduced discharge in NREM sleep, and were silent or nearly silent in REM sleep. Calibration: EMG, 100 V; Hipp, 50 V; EOG,
50 V; EEG, 50 V. Abbreviations as in Figure 2 and 3 legends.
Wake-Active Cells Have Similar Discharge Rates charge rate during AW and significantly reduced dis-
charge rates during NREM sleep (t  4.4; df  18; p in QW and Cataplexy
The second largest group of cells (12%) in the ventral 0.01; Bonferroni t test) and REM sleep (t  3.6; df  18;
p  0.01; Bonferroni t test) compared to AW (Figure 7C;PLH region, wake-active neurons, showed maximal dis-
Histamine Cell Discharge in Cataplexy
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Figure 5. Effect of Drugs Affecting Cataplexy or Alertness on the Activity of REM-Off Cells, GABA Release, and Severity of Cataplexy
(A) Histaminergic REM-off cells remained active or increased activity in waking after the administration of the anticholinesterase physostigmine
salicylate (n  6), the 1 antagonist prazosin (n  2), and the 2 agonist BHT-920 (n  3), as compared to pretreatment (basal activity taken
as 100%). Noradrenergic (NE) REM-off cells reduced their discharge rate after the administration of physostigmine (n  3) and prazosin (n  6;
Wu et al., 1999). Serotonergic (5-HT) REM-off neurons also reduced their discharge rate after prazosin (n  15; Wu et al., 2004). The rate
changes that are shown preceded cataplexy attacks, which were accompanied by further rate decreases in serotonergic and noradrenergic
cells, but not in histaminergic cells.
(B) The mean discharge rate in waking shows that the activity of histaminergic cells did not change (t  0.075; df  16; p  0.94), and
noradrenergic (t  4.2; df  16; p  0.001) and serotonergic (t  2.2; df  28; p  0.05) cell activity was significantly reduced after the
administration of cataplexy-inducing drugs.
(C) Effect of histaminergic and noradrenergic antagonists on severity of cataplexy. The modified food elicited cataplexy test was done after
intravenous administration (n  5) of the 1 antagonist prazosin, the H1 antagonist mepyramine, the H3 (autoreceptor) agonist
-methylhistamine, and normal saline (control). The H1 antagonist and the H3 agonist did not alter cataplexy time, whereas the 1 antagonist
greatly increased cataplexy. **p  0.05.
(D) GABA release in the ventral PLH was significantly higher in NREM sleep compared to waking (*p  0.05). In cataplexy (n  16), GABA
release was significantly reduced when compared with REM sleep (n  9), NREM sleep (n  23), and waking (n  15) states. **p  0.01.
Abbreviations as in Figure 2 and 3 legends.
Table 1). Mean firing rates during NREM sleep (t  3.2; lower than that in QW (Figure 7C). The mean discharge
rate during cataplexy was nonsignificantly higher thandf  18; p  0.05; Bonferroni t test) and REM sleep (t 
2.6; df 18; p 0.05; Bonferroni t test) were significantly those in NREM sleep and REM sleep but was lower than
Neuron
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Figure 6. Activity of Ventral PLH Wake/REM-
Active Neurons across the Sleep-Wake Cycle
and in Cataplexy
(A) Single-cell discharge (unit 1 and unit 2)
patterns (0.2 s bin) across sleep-wake epi-
sodes. Gray bars, NREM sleep; unfilled bars,
active waking (AW).
(B) Enlarged view of the area indicated by a
box in (A).
(C) Episodes of NREM and REM sleep.
(D) Episodes of AW and cataplexy (last AW
episode unlabeled). Calibration: Hipp, 50 V;
EOG, 50 V; EEG, 50 V. Abbreviations as in
Figure 2 and 3 legends.
that in AW (Figure 7D; Table 1). The average activity of State-Independent and Other Cells Fire
during Cataplexythis group of cells during cataplexy was comparable to
that seen during QW (Figure 7D; Table 1). Cells in the state-independent category did not show
substantial changes in their discharge rates across S-W
states or in cataplexy (Figures 7G and 7H; Table 1).REM-Active Cells Do Not Alter Firing in Cataplexy
In the category of “other,” three neurons in NREMCompared with QW but Fire Less in Cataplexy
sleep and two in QW showed maximal discharge, andThan in REM Sleep
the remaining cells showed a high discharge rate inREM-active cells showed maximal tonic discharge rate
more than one S-W state (Table 1). On average, theseselectively during REM sleep (Figure 7E; Table 1). These
cells were somewhat more active during cataplexy thancells had an average firing rate in REM sleep that was
in QW (Table 1).five times higher than that in AW (t  3.1; df  6; p 
0.05; Bonferroni t test; Table 1). Their firing rate during
REM sleep was also significantly higher than their firing Hippocampal Theta Activity Is Present
during Cataplexyrate in QW (t  3.4; df  6; p  0.05; Bonferroni t
test; Table 1). REM-active cells showed a nonsignificant Hippocampal theta activity was pronounced during cat-
aplexy episodes, along with muscle tone suppressionincrease in discharge rate during cataplexy, as com-
pared to those in AW, QW, and NREM sleep, but this (Figure 8). Theta (3.5–6 Hz) power varied significantly
among REM sleep, cataplexy, NREM sleep, QW, andrate was lower than the REM sleep discharge rate (Figure
7F; Table 1). AW states (F  41.4; df  4,3; p  0.0001; ANOVA).
Histamine Cell Discharge in Cataplexy
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Theta power was significantly higher in cataplexy than
in both AW and QW (p 0.05 and p 0.01, respectively;
Dunn’s [Bonferroni] test), as was also true for REM sleep
with respect to AW and QW (p  0.01 for both; Dunn’s
[Bonferroni] test). However, theta power was lower in
cataplexy than in REM sleep (p  0.01; Dunn’s [Bonfer-
roni] test).
Discussion
Identification of Histamine Cells
Histamine-containing cells are localized to the tubero-
mammillary region of the posterior hypothalamus in the
rat, cat, and human (Lin et al., 1988; Panula et al., 1984,
1990; Reiner and McGeer, 1987; Sakai et al., 1990;
Steininger et al., 1999; Vanni-Mercier et al., 2003; Wata-
nabe and Yanai, 2001; Watanabe et al., 1984). We find
a similar localization in the narcoleptic dog, with hista-
mine-IR cells concentrated in the ventral posterior hypo-
thalamus and adjacent mammillothalamic and periforn-
ical regions. Histamine cells are concentrated in a region
caudal to but having some overlap with the region con-
taining hypocretin/orexin (Hcrt) cells (Thannickal et al.,
2000a, 2000b).
Cells that cease discharge in REM sleep (REM-off)
have been recorded in posterior hypothalamic regions
that contain histamine-IR cells (Sakai et al., 1990; Vanni-
Mercier et al., 2003). In rats and cats, it has been shown
that these posterior hypothalamic REM-off cells have
long-duration action potentials, a property shown to
be unique to histamine-containing cells in this region
(Reiner and McGeer, 1987; Sakai et al., 1990; Uteshev
et al., 1995; Vanni-Mercier, 2003). The REM-off cells that
we have observed in the canine posterior hypothalamus
have significantly longer action potentials than other cell
types that we have recorded from within this area.
Activity of Histamine, Norepinephrine,
and Serotonin Cells in Cataplexy
We have found that, during cataplexy attacks, presumed
histamine-containing cells fire at levels similar to or
higher than those seen in quiet waking (QW). Our micro-
dialysis-HPLC measurements showed that GABA re-
lease into the tuberomammillary nucleus was signifi-
cantly reduced in cataplexy relative to sleep and waking
levels. This reduction in GABA release is likely to disin-
hibit histamine cells (Nitz and Siegel, 1996). Along with
increased forebrain excitation, this may explain the
maintained discharge of histamine cells at a time when
noradrenergic and serotonergic neurons are decreasing
Figure 7. Discharge Patterns of PLH Wake/REM-Active, Wake-
activity. Sherin et al. (1998) have demonstrated that his-Active, REM-Active, and State-Independent Neurons
tamine neurons receive a major GABAergic projection(A) Firing patterns of wake/REM-active neurons across sleep-wake
from the ventrolateral preoptic area (VLPO). In earlierstates (n  77).
work (Sherin et al., 1996), they demonstrated that neu-(B) Mean discharge rates  SEM of wake/REM-active neurons that
were also recorded during cataplexy (n  45). rons in the VLPO were selectively active during sleep. In
(C) Discharge patterns of wake-active neurons across sleep-wake the current work, this linkage between sleep and GABA
states (n  19). release is shown to be maintained, with reduced GABA
(D) Mean discharge rates  SEM of wake-active neurons during
release under conditions of cataplexy, a state of alertcataplexy and sleep-wake states (n  9).
waking. The presumed reduction of activity in VLPO(E) Firing patterns of REM-active neurons across sleep-wake states
(n  7).
(F) Mean discharge rates  SEM of REM-active neurons that were
also recorded during cataplexy (n  5).
(G) Firing patterns of state-independent neurons across sleep-wake (H) Mean discharge rates SEM of state-independent neurons that
states (n  11). were recorded during cataplexy (n 5). Abbreviations as in Figure 3.
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Figure 8. Hippocampal EEG Power Spectrum across Sleep-Wake States and in Cataplexy
Hippocampal theta (3.5–6 Hz) power is significantly higher in REM sleep than in other sleep-waking states. Theta power is significantly higher
during cataplexy than in AW and QW but lower than in REM sleep. Hippocampal EEG and EMG are also shown for each state. Power on
y axis is presented in arbitrary units. **p  0.01, compared to AW and QW.
sleep-active neurons during cataplexy allows continued taminergic REM-off cells differ dramatically in their ac-
tivity profiles during cataplexy. We have reported thatactivity in histamine neurons, which in turn supports
other physiological changes that are required for the presumed noradrenergic cells of the LC decrease
firing prior to cataplexy, cease firing during cataplexy,waking.
The maintained discharge of histamine cells during and resume firing immediately prior to the offset of cata-
plexy (Wu et al., 1999). This discharge profile is consis-cataplexy is consistent with what we know about the
state of cataplexy and the role of histamine cells in tent with other work showing that muscle tone suppres-
sion that is triggered by brainstem activation is linked tomaintaining wakefulness. The histamine neurons of the
hypothalamus have strong projections to EEG arousal- cessation of norepinephrine release onto motoneurons
(Lai et al., 2001). We have further shown that LC neuronsrelated areas in the forebrain and brainstem (Lin et al.,
1988). Injection of histamine agonists produces ex- are silenced when pontine or medullary stimulation is
used to trigger muscle tone suppression (Mileykovskiytended arousal (Lin et al., 1994), and antihistamines im-
pair alertness (Bender et al., 2003). et al., 2000). When the pontine pathway to the LC is
blocked, stimulation of motor inhibitory sites in the ponsWe find that the noradrenergic, serotonergic, and his-
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and medulla produces motor excitation rather than inhi- Guilleminault and Anognos, 2000) or in the canine Hcrtr2
bition (Kohyama et al., 1998; Siegel et al., 1983; Siegel mutant narcoleptic, as shown in the current study.
and Tomaszewski, 1983). Therefore, activation of the
brainstem muscle tone suppression system that causes Other Cell Types
the release of glycine and GABA onto motoneurons We identified six cell types with different S-W discharge
(Chase and Morales, 2000; Kodama et al., 2003) also profiles, in addition to those of the presumed histaminer-
causes a cessation of LC discharge and consequent gic cells of the ventral PLH. Neurons in this area exhibit
reduction of norepinephrine release onto motoneurons. a number of different neurotransmitter phenotypes and
This cessation of LC discharge is linked to the suppres- projection patterns (Lantos et al., 1995). It remains to
sion of muscle tone in the decerebrate animal, to the be determined how the sleep cycle and cataplexy dis-
normal atonia of REM sleep, and to the pathological charge patterns that we see relate to the other charac-
loss of muscle tone in cataplexy (Siegel et al., 1991, teristics of these cell groups.
1992). Inactivation of the LC causes a reduction of ipsi-
lateral muscle tone (Andre et al., 1992; D’Ascanio et Hippocampal Theta
al., 1988). In contrast, lesion of the histamine cells or In this paper, we have replicated and extended prior
complete disconnection of histamine cells from motor indications that hippocampal theta is elevated during
systems by transection of the neuraxis does not diminish cataplexy (Kushida et al., 1985) as it is during REM sleep
muscle tone (T.C. Chou et al., 2001, Soc. Neurosci., (Prospero-Garcia et al., 1993). Figure 8 shows that the
abstract; Lai and Siegel, 1991). amplitude of theta in cataplexy approaches that in REM
Locus coeruleus cells, which have extensive rostral sleep and is significantly larger than that seen in ac-
projections, are active in relation to alert waking behav- tive waking.
iors (Aston-Jones et al., 2001). However, the alert waking The elevated theta, reduced muscle tone, and re-
state of cataplexy arises despite a complete cessation duced activity of noradrenergic LC cells and seroton-
of LC discharge. Thus, although activity in LC cells con- ergic dorsal raphe cells are among the most striking-
tributes to cortical arousal, it is not required for mainte- similarities between cataplexy and REM sleep. The
nance of the alert waking state during cataplexy epi- persistent activity of histamine cells and the mainte-
sodes. nance of environmental awareness in cataplexy, how-
We report that, during cataplexy, dorsal raphe neu- ever, contrast with the cessation of histamine activity
rons have a discharge pattern that is intermediate be- and loss of environmental awareness in REM sleep.
tween that of cells in the LC (Wu et al., 1999, 2004) and
that of histamine-containing cells. In addition, we have Histamine and Hypocretin
found that brainstem stimulation that suppresses mus- Most human narcolepsy is caused by a loss of Hcrt
cle tone also reduces serotonin release onto motoneu- neurons (Thannickal et al., 2000a) and a consequent
ron pools (Lai et al., 2001). The reduction in discharge reduction in Hcrt levels (Peyron et al., 2000). Gliosis
that we have seen in the dorsal raphe cells of narcoleptic accompanying the loss of Hcrt cells is consistent with
dogs during cataplexy might be sufficient to produce
the hypothesis that this loss occurs postnatally and that
the reduction in serotonin release seen in brainstem
it is accompanied by inflammation (Thannickal et al.,
stimulation-induced muscle tone suppression. How-
2000a). Hcrt cells densely innervate histamine cells (Er-
ever, since the dorsal raphe nucleus has largely as-
iksson et al., 2001). We recently found that gliosis iscending projections, it is unlikely that this nucleus is
most intense in the posterior hypothalamus, suggestingresponsible for a significant portion of the serotonin
that the loss of Hcrt terminals in this region and therelease seen in motoneuron pools. Rather, the main
consequent loss of Hcrt innervation of histamine cellssources of serotonin in spinal and brainstem motoneuro-
may be important components of the pathology of nar-nal pools are the pontine and medullary raphe groups.
colepsy (Thannickal et al., 2003).We speculate that, during cataplexy, these cell groups
Canine genetic narcolepsy is caused by a mutationmay behave more like LC neurons than dorsal raphe
in the Hcrtr2 gene rather than a loss of Hcrt neuronscells. The ascending projections of dorsal raphe cells
(Lin et al., 1999; Thannickal et al., 2000b). However,may make some contribution to cortical arousal in cata-
canine and human narcolepsy are similar in their symp-plexy as well as in normal waking (Jacobs and Azmitia,
toms, physiology, behavioral triggers, and response to1992; Wu et al., 2004), along with the activity of hista-
pharmacological agents, suggesting that most of themine cells.
symptoms are triggered downstream of the Hcrt cellThe administration of prazosin or physostigmine, both
loss or receptor malfunction that causes the disorder,of which precipitate cataplexy, significantly decreases
particularly at the level of monoamine neurons (Siegel,the activity of noradrenergic and serotonergic cells prior
1999).to the onset of cataplexy episodes, whereas these same
It is important to note that the direct effects of thedrugs either do not change or slightly increase the activ-
complete loss of Hcrtr2 function in Hcrtr2 mutant dogsity of histaminergic cells prior to cataplexy episodes
cannot explain the clear-cut differences in the activity(Figure 5). The most effective drugs for treating cata-
of norepinephrine, serotonin, and histamine cells duringplexy in both narcoleptic dogs and humans are those
cataplexy. In the normal animal, all three cell groups arethat manipulate the monoamine systems, with noradren-
excited by Hcrt (Hagan et al., 1999; Horvath et al., 1999;ergic agonists being particularly important in treating
Ivanov and Aston-Jones, 2000; van den Pol et al., 2002;cataplexy (Nishino et al., 1993). Antihistamines impair
Bourgin et al., 2000; Li et al., 2002; Bayer et al., 2001).alertness in normals and narcoleptics but do not in-
crease cataplexy in human narcoleptics (Aldrich, 1998; LC cells have predominantly Hcrtr1, and histamine cells
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Figure 9. Model for the Mechanism of Cataplexy and Sleepiness in Narcolepsy
Locus coeruleus noradrenergic neurons (LC) may be involved in the maintenance of muscle tone, and posterior hypothalamus histamine
neurons (HA) may be involved in the maintenance of alertness in cataplexy. In quiet waking, non-Hcrt excitatory inputs are reduced. Thicker
input symbolizes more release of neurotransmitters. Net level of neuronal activity is given schematically for each state. Hcrtr, Hypocretin
receptor; KO, knockout.
have predominantly Hcrtr2. Therefore, one might expect this receptor does not mediate the sleep cycle modula-
tion of discharge in the histamine cells or in LC or raphethat histamine cells would have abnormal slowing in the
Hcrtr2 mutant dogs and that LC cells would have normal cells. The discharge rate of histamine REM-off cells in
waking has been reported to be 2.4 Hz in cats and 3.9discharge (and serotonergic cells would have an inter-
mediate pattern). Instead, we see just the reverse during Hz in rats (Sakai et al., 1990; Steininger et al., 1999;
Vanni-Mercier et al., 2003). We find it to be 4.8 Hz in ourcataplexy. LC cells have abnormal slowing, whereas
histamine cells maintain waking discharge levels dur- Hcrtr2 mutant dogs. Since Hcrt is excitatory to histamine
cells, this difference in rate could not be a direct effecting cataplexy.
It is also clear that the overall REM-off profile is pres- of the loss of Hcrtr2, but might be a result of species dif-
ferences.ent in norepinephrine, serotonin, and histamine cells
even in the absence of functional Hcrtr2, indicating that We present a model (Figure 9) that can explain some
Histamine Cell Discharge in Cataplexy
631
of our observations by incorporating known Hcrt and Model of the Role of Hcrt in the Control
of Histamine and Hcrt Neuronsnon-Hcrt effects, known afferents, projections and ac-
in Relation to Sleepinesstions of LC and histamine cells, and hypothesized ac-
Type 2 Hcrt receptors on histamine neurons have ations of Hcrt receptors on the self-excitation of Hcrt
major role in preventing sleepiness during waking. Aneurons. This model considers and incorporates recent
reduction of histamine levels has been seen in the cere-findings by Willie et al. (2003) and Kisanuki et al. (2001)
brospinal fluid of Hcrtr2 mutant narcoleptic dogs (Ni-that indicate that cataplexy is more severe in ligand
shino et al., 2001) and narcoleptic humans (Nishino etknockout (KO) and Hcrtr1 KO animals than in Hcrtr2
al., 2002). It is well known that antihistamines causeKO animals and that sleepiness is worse in Hcrtr2 KO
sleepiness and that stimulation of histamine cells pro-animals.
duces arousal (Bender et al., 2003; Guilleminault and
Anognos, 2000; Lin et al., 1994). The arousing effect
of Hcrt has been shown to be heavily dependent onModel of the Role of Hcrt in the Control
activation of histamine-containing cells (Huang et al.,of Norepinephrine, Histamine, and Hcrt Neurons
2001; Ishizuka et al., 2002). In normals, as non-Hcrt inputin Relation to Cataplexy
diminishes in extended quiet waking periods, Hcrt neu-Type 1 Hcrt receptors, the dominant Hcrt receptor type
rons, which are tonically active in the absence of inputon LC noradrenergic neurons, have an important role in
(Eggermann et al., 2001), continue to release the peptidefacilitating muscle tone during certain types of emotion-
at a basal level (Bayer et al., 2001; Eriksson et al., 2001;
ally excited waking, thereby preventing cataplexy (Fig-
Yamanaka et al., 2002; Figure 9). In Hcrtr1 KO animals,
ure 9). In the normal animal, during nonexcited waking,
effective Hcrt stimulation of histamine cells is possible;
Hcrt tonically facilitates the LC via Hcrtr1. The net effect however, we hypothesize that the positive feedback
of other inputs is also facilitatory. In moderately and loop underlying recruitment of Hcrt cells is impaired by
highly excited waking states, non-Hcrt inputs decrease, the mutation. This results in an intermediate level of
as evidenced by the transient muscle weakness seen excitation of histamine cells and consequent sleepiness.
in normal individuals during certain emotionally charged In Hcrtr2 KO/mutant animals, no effective Hcrt excitation
behaviors, such as laughter or surprise. Hcrt release of histamine cells occurs, resulting in reduced histamine
increases to compensate for this, allowing muscle tone cell activity and severe sleepiness whenever non-Hcrt
to be maintained. inputs to these cells are reduced (e.g., in quiet waking).
In Hcrt receptor-1 KO animals, there is no substantial In human narcoleptics, the loss of Hcrt cells will produce
Hcrt input to the LC under any condition because of Hcrtr1 and Hcrtr2 KO effects. This model predicts that
the absence of functional Hcrtr1. As non-Hcrt input de- Hcrtr2 KOs/mutants will be sleepier than Hcrtr1 KOs
creases, cataplexy rapidly occurs. and supplementation will be more effective in reversing
sleepiness in Hcrtr1 KOs. Hcrt supplementation shouldIn contrast, there is tonic Hcrt input to LC neurons in
be effective in human narcoleptics, who are likely toHcrtr2 mutant dogs and mice through the intact Hcrtr1.
have intact Hcrtr1 and Hcrtr2. The selectively increasedHowever, we hypothesize that the lack of functional
loss of Hcrt cells and axons and the increased gliosisHcrtr2 disrupts the hypothalamic positive feedback loop
seen in the posterior hypothalamus of human narcolep-(Li et al., 2002) responsible for elevated levels of Hcrt
tics suggest that this region is a focus of inflammationrelease with excitement in normal animals. This prevents
and damage in human narcolepsy.or diminishes excitation of Hcrt neurons, resulting in
cataplexy of lesser intensity than that seen in Hcrtr1 or
Conclusionligand KOs.
We find that cataplexy is the only condition in which theIn Hcrtr2 mutant narcoleptic dogs, little Hcrt effect
levels of activity of different monoaminergic cell groupswould be expected on histamine cells, which contain
diverge over sustained time periods. This provides aprimarily Hcrtr2. We hypothesize that the histamine
unique insight into their functional roles. Histamine cellscells receive excitatory input from limbic regions acti-
remain active during cataplexy. The maintenance of his-
vated during the emotional stimulation responsible
tamine cell discharge, together with the concurrent loss
for triggering cataplexy (Gulyani et al., 2002). GABA of discharge in LC and activation of medullary motor
release, originating from hypnogenic neurons of the inhibitory neurons that we have reported previously in
VLPO, is greatly reduced during cataplexy, because canine narcoleptics (Siegel et al., 1991), can explain
VLPO GABAergic neurons are inhibited by forebrain lim- the unique characteristics of cataplexy, which combines
bic regions (Chou et al., 2002) that are activated during loss of muscle tone with maintenance of environmental
emotional stimulation. This accounts for the maintained awareness. The divergent patterns of discharge of the
activity of histamine neurons during cataplexy when REM-off cell groups in cataplexy support the concept
compared with quiet waking states. that activity in histamine cell groups is strongly linked
This model explains the more intense cataplexy re- to forebrain arousal, whereas serotonergic and norad-
ported in ligand KO and Hcrtr1 KO animals as compared renergic cells have important roles in the regulation of
to Hcrtr2 KO animals and predicts that Hcrt supplemen- muscle tone and perhaps the coordination of motor ac-
tation will be more effective in blocking cataplexy in tivity with forebrain arousal.
Hcrtr2 KO/mutant animals (John et al., 2000) than in
Experimental ProceduresHcrtr1 KO animals (Figure 9). Humans with loss of Hcrt
neurons will have symptoms of both Hcrtr1 and Hcrtr2 Animals
deficiency, attenuated by residual Hcrt from surviving Four genetically narcoleptic (Hcrtr2 mutant; Lin et al., 1999) Dober-
man pinschers (3 males, 1 female; 4.5  1.3 years) were used.Hcrt neurons (Thannickal et al., 2000a).
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All the procedures were in accordance with the National Research Pharmaceuticals, Inc., St. Louis, MO), the 1 antagonist prazosin
hydrochloride (0.5 mg/kg, p.o.; UDL Laboratories Inc., Rockford, IL),Council Guide for the Care and Use of Laboratory Animals and were
approved by the Animal Research Committees of the University of and the 2 agonist BHT-920 (2 g/kg, i.v.). The effect of prazosin
on cell activity was monitored between 2 and 2.5 hr after drugCalifornia at Los Angeles and of the Veterans Administration Greater
Los Angeles Healthcare System. administration, and the effect of physostigmine was assessed be-
tween 5 and 10 min after injection, the time periods during which
they have their most marked effects on cataplexy probability (WuSurgery
et al., 1999). The effect of BHT-920 was assessed between 5 andUnder isoflurane anesthesia, electrodes for the assessment of differ-
30 min after injection.ent S-W stages (EEG, EMG, EOG, and hippocampal EEG) were
chronically implanted as described earlier (Siegel et al., 1991; Wu
et al., 1999). To record unit activity, microdrive assemblies with 25 Microdialysis and High-Pressure Liquid Chromatography
and 64 m stainless steel microwires (California Fine Wire Co., Gro- Microdialysis probes (A-I-Model; Eicom Corp., Kyoto, Japan) with
ver Beach, CA) were stereotaxically implanted into the tuberomam- 1 mm long membranes were inserted through the guide cannulae
millary area of the ventral PLH (A 21, L 3, H 12; Lim et al., 1960). In 12 hr prior to the study. Artificial cerebrospinal fluid (Harvard Appa-
two dogs, cannulae were implanted into the ventral PLH for the ratus, MA) was continuously perfused at 2l/min through the ventral
microdialysis experiments. PLH probes for 2 hr prior to the experiment. Dialysate was collected
every 5 min during waking, NREM sleep, REM sleep, and cataplexy.
Recording of Unit Activity during S-W Stages and Cataplexy For the induction of prolonged cataplexy, apomorphine (D-2 agonist;
The dogs were free to move around the recording chamber (1.2 m 4 mg/kg, i.v.; Sigma) was given 90 min after the administration of the
1.2 m  1.2 m). Signals for the assessment of different S-W stages dopamine receptor antagonist domperidone (1 mg/kg, i.v.; Sigma),
were amplified with a Grass model 78 E Polygraph (Grass Instru- which does not cross the blood-brain barrier (M.-F. Wu et al., 2003,
ments, Quincy, MA). All the recordings were carried out between Soc. Neurosci., abstract). Apomorphine produces complete cata-
09:00 and 18:00 hr. Single-cell activity was recorded during S-W plexy within 2 min of injection, and this lasted more than 40 min.
stages and food elicited cataplexy tests (FECTs). Samples were collected prior to, during, and after cataplexy epi-
Stable single units with a signal-to-noise ratio of at least 3:1 were sodes. The concentration of GABA in the dialysate was detected
studied for at least three episodes of various S-W stages (Wu et al., by HPLC (EP-300; Eicom Corp., Kyoto, Japan) with fluorescent de-
2004). Many of these cells were also recorded during cataplexy tection (excitation/emission 340/440 nm), as described in our prior
attacks in waking. All slow wave and unit activity signals were digi- studies (John et al., 2003; Kodama et al., 2003).
tized using a CED 1401 Plus interface and analyzed using Spike2
software (Cambridge Electronic Design Ltd., Cambridge, UK). Six
Effect of Histaminergic and Noradrenergic Antagonistssamples from each episode were used for power spectral analysis.
on CataplexySpike duration was determined from the onset of the negative com-
The modified food elicited cataplexy test (Boehmer et al., 2004)ponent to the offset of the positive component using averaged wave-
was done 10 min after intravenous administration (n  5) of the 1forms taken from 200 action potentials.
antagonist prazosin (80 g/kg; Sigma), the H1 antagonist mepyra-Cells were held for recording as long as needed to complete
mine (500 g/kg; Tocris, UK), the H3 (autoreceptor) agonistthe experimental protocol, up to 3 days in some cases. The spike
-methylhistamine (500 g/kg; Tocris, UK), and 0.9% saline (aswaveform shape, absence of abrupt change in amplitude or optimal
control).microwire derivations, maintenance of discharge profile over the
sleep cycle, and the waking behavioral correlates of discharge
Immunohistochemical Localization(Siegel and Tomaszewski, 1983; Siegel et al., 1983) allowed us to
of Histaminergic Neuronsconfirm that the same cells were recorded across multiple re-
At the end of the study, a 15 A anodal current was passed throughcording sessions.
the microelectrodes for 20 s to make an iron deposit at the tip of
the electrode (Wu et al., 1999). Dogs were sacrificed by an overdoseClassification of S-W Stages and Cataplexy
of sodium pentobarbital (50 mg/kg, i.v.) and transcardially perfusedSleep-wake stages and cataplexy were classified based on electro-
with buffered saline and paraformaldehyde. The brains were equili-physiological parameters and visual observation as previously de-
brated in 30% sucrose, and 40m coronal sections of the hypothala-scribed (Siegel et al., 1991; Wu et al., 1999). In this study, cataplexy
mus were cut on a cryostat.was induced by the introduction of food or play objects or occurred
Histamine staining was done on a one-in-four series of hypothala-spontaneously as previously described (John et al., 2000; Wu et al.,
mic sections (120 m interval). Free-floating sections were incu-1999). The discharge profile of each neuron was recorded over a
bated for 72 hr at 4	C on an agitator with rabbit antihistamine antise-minimum of five complete cataplexy episodes.
rum (DiaSorin, Stillwater, MN) diluted 1:7500 in phosphate-buffered
saline (PBS) containing 0.1% Triton X-100 and 4% normal goatClassification of Neurons Based on Their Discharge Profile
serum. They were rinsed and incubated with biotinylated anti-rabbitThe wake/REM-active type was defined by high firing rates in both
IgG (1:200 in PBS) and 4% normal goat serum for 2.5 hr. The sectionsAW and REM sleep and lowest firing rates in NREM sleep (80%
were then rinsed and incubated in 1:100 ABC in PBS for 2 hr (Vectorof mean AW firing rate). Wake-active cells were defined to be those
Laboratories, Inc., Burlingame, CA). After being rinsed with Tris-cells with highest activity in AW, with firing rates during REM and
buffered saline, sections were incubated for 5–10 min in 0.05%NREM sleep that were 10%–80% of the mean firing rates during
diaminobenzidine and 0.001% H2O2, yielding a brown precipitateAW. NREM-off cells were defined as those cells whose firing rates
in histamine-IR neurons. Control sections processed without thewere10% in NREM sleep and 10%–50% in REM sleep of the mean
antihistamine antiserum showed no specific staining or labeledfiring rates in AW. REM-off cells were defined to be those cells
neurons.whose firing rates in REM sleep were 10% of the mean firing
One series of hypothalamic sections was rinsed in 5% potassiumrates in AW. REM-active cells were defined to be those cells whose
ferrocyanide for the Prussian blue reaction to locate the iron deposithighest discharge rates occurred during REM sleep. State-indepen-
at the tip of the electrode and then stained with cresyl violet. Map-dent (SI) cells were defined to be those whose firing rates in NREM
ping of histamine-IR neurons and reconstruction of the electrodeand REM sleep were within 20% of their mean AW firing rate. Cells
tract were done with the help of a Neurolucida Imaging Systemthat did not fit into any of the above categories were classified
(Microbrightfield, Colchester, VT).as “other.”
Effects of Cataplexy-Inducing Drugs on REM-Off Cell Activity Data Analysis
All mean discharge rate values were expressed as action potentialsThe following cataplexy-enhancing drugs were administered to
study their effects on the discharge rates of REM-off cells: the per second  standard error. Spike widths, hippocampal theta
power, and microdialysis data were compared by one-way analysisanticholinesterase physostigmine salicylate (50 g/kg, i.v.; Forest
Histamine Cell Discharge in Cataplexy
633
of variance (ANOVA), followed by post hoc comparisons using Cataplexy-related neurons in the amygdala of the narcoleptic dog.
Neuroscience 112, 355–365.Dunn’s (Bonferroni) test.
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